- Home
- VERA vs JBLU Comparison
VERA vs JBLU Comparison
Compare VERA & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- JBLU
- Stock Information
- Founded
- VERA 2016
- JBLU 1998
- Country
- VERA United States
- JBLU United States
- Employees
- VERA N/A
- JBLU N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- VERA Health Care
- JBLU Consumer Discretionary
- Exchange
- VERA Nasdaq
- JBLU Nasdaq
- Market Cap
- VERA 2.0B
- JBLU 1.5B
- IPO Year
- VERA 2021
- JBLU N/A
- Fundamental
- Price
- VERA $23.50
- JBLU $4.37
- Analyst Decision
- VERA Buy
- JBLU Sell
- Analyst Count
- VERA 8
- JBLU 11
- Target Price
- VERA $64.63
- JBLU $4.97
- AVG Volume (30 Days)
- VERA 1.5M
- JBLU 19.7M
- Earning Date
- VERA 08-07-2025
- JBLU 07-29-2025
- Dividend Yield
- VERA N/A
- JBLU N/A
- EPS Growth
- VERA N/A
- JBLU N/A
- EPS
- VERA N/A
- JBLU N/A
- Revenue
- VERA N/A
- JBLU $9,210,000,000.00
- Revenue This Year
- VERA N/A
- JBLU N/A
- Revenue Next Year
- VERA N/A
- JBLU $7.75
- P/E Ratio
- VERA N/A
- JBLU N/A
- Revenue Growth
- VERA N/A
- JBLU N/A
- 52 Week Low
- VERA $18.53
- JBLU $3.34
- 52 Week High
- VERA $51.61
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- VERA 52.21
- JBLU 46.08
- Support Level
- VERA $22.57
- JBLU $4.25
- Resistance Level
- VERA $24.26
- JBLU $4.50
- Average True Range (ATR)
- VERA 1.14
- JBLU 0.20
- MACD
- VERA 0.08
- JBLU 0.02
- Stochastic Oscillator
- VERA 63.39
- JBLU 70.00
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.